Online Inquiry

Regadenoson

* Please be kindly noted products are not for therapeutic use. We do not sell to patients.

Category Standards
Catalog NO. BPG-3146
Product Name Regadenoson
CAS 313348-27-5
Molecular Formula C15H18N8O5
Molecular Weight 390.35
Regadenoson

Ordering Information

Catalog Number Size Price Stock Quantity
BPG-3146 25 mg $199 In stock
Inquiry
  • Scheme Design
  • Custom Synthesis
  • cGMP Manufacturing
  • Quality Assurance
  • Product Information
  • Application
  • References
  • Documents
  • Reviews

Product Information

Description Regadenoson, as a coronary vasodilator it is a selective A2A adenosine receptor agonist in myocardial imaging.
Synonyms 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide
CVT 3146
CVT-3146
CVT3146
Lexiscan
regadenoson
IUPAC Name 1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide
Canonical SMILES CNC(=O)C1=CN(N=C1)C2=NC3=C(C(=N2)N)N=CN3C4C(C(C(O4)CO)O)O
InChI 1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1
InChIKey LZPZPHGJDAGEJZ-AKAIJSEGSA-N
Boiling Point 744.10°C at 760 mmHg
Melting Point 194-196°C
Purity >99%
Density 1.98±0.1 g/cm3
Solubility Soluble in DMSO
Related CAS 313348-27-5 (free) 875148-45-1 (hydrate)
Appearance Off-White to Pale Beige Solid
Application A selective A2A adenosine receptor agonist in myocardial imaging.
Shelf Life 2 years
Storage Store at -20°C
Exact Mass 390.14
Hygroscopic No
Light Sensitive No
Percent Composition C 46.15%, H 4.65%, N 28.71%, O 20.49%
Pictogram(s) Acute Toxic, Irritant, Health Hazard
Signal Danger
Precautionary Statement Codes P260, P261, P262, P264, P264+P265, P270, P271, P280, P284, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P308+P316, P316, P317, P320, P321, P330, P332+P317, P337+P317, P361+P364, P362+P364, P403+P233, P405, and P501
References 1. Cerqueira MD. The future of pharmacologic stress: selective A2A adenosine receptor agonists. Am J Cardiol. 2004 Jul 22;94(2A):33D-40D; discussion 40D-42D. doi: 10.1016/j.amjcard.2004.04.017. PMID: 15261132. PubMed ID: 15261132.
2. Kim DG, Bynoe MS. A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier. J Clin Invest. 2016 May 2;126(5):1717-33. doi: 10.1172/JCI76207. Epub 2016 Apr 4. PMID: 27043281; PMCID: PMC4855938. PubMed ID: 27043281.

Reviews

If you have any suggestions or comments about mPEG-Br, please submit a review immediately.

submit

Related Link

Why BOC Sciences?

  • Large Stock

    More than 2000+ products in inventory

  • Global Delivery

    Warehouses in multiple cities to ensure fast delivery

  • mg to kg

    Multi specification for academic research and industrial production

  • 24/7 Technical Support

    Strict process parameter control to ensure product quality

Products

Resources

Our Feature

BOC Sciences supplies a unique variety of PEG derivatives and functional PEG polymers. Our products offer the most diverse collection of reactivity, ready-to-use functionality, and molecular weight options that you will not find anywhere else.

  • Our Feature icon1
  • Our Feature icon2
  • Our Feature icon3
  • Our Feature icon4
PEGylation of Peptides and Proteins

PEGylation of Peptides
and Proteins

Reduce the Immunogenicity of Peptide/Protein Drugs

Learn More

APPLICATIONS

APPLICATIONS

PEG linkers For Drug

Improved Circulation Half-Life

Learn More

Have Customer Reviewed On Us?

logo

Chat With Us

Online Inquiry

Verification code

Copyright © 2024 BOC Sciences. All rights reserved.

Inquiry Basket